Skip to main content

Table 1 Neurological conditions associated with COVID-19

From: Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings

Clinical conditions associated with COVID-19 affecting the central nervous system No. of patients / Proportion
Encephalopathy 990 (60·7%)
Unspecified stroke type 416 (25·5%)
Ischemic stroke 159 (9·7%)
Hemorrhagic stroke 40 (2·4%)
Encephalitis and meningoencephalitis 19 (1·2%)
Acute disseminated encephalomyelitis (ADEM) 4 (0·2%)
Venous sinus thrombosis 3 (0·2%)
Multiple sclerosis exacerbation 2 (0·1%)
Total 1633 (100%)
Clinical conditions associated with COVID-19 affecting the peripheral nervous system No. of patients / Proportion
Guillain-Barré syndrome 22 (51·2%)
Other cranial nerve disorders 12 (27·9%)
Facial palsy (Bell syndrome) 5 (11·6%)
Miller-Fisher syndrome and polyneuritis cranialis 4 (9·3%)
Total 43 (100%)